PharmiWeb

Icotrokinra shows superiority to deucravacitinib in first reported head-to-head trials reinforcing promise of investigational targeted oral peptide for treatment of plaque ...

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event rates to placebo in Phase 3 ICONIC-ADVANCE studies.1 Icotrokinra also showed ...
Sinar Daily on MSN

Psoriasis not just skin deep, impacts mind too

Their condition often worsens when exposed to scorching sunlight or hot environments, leading patients to feel self-conscious ...

Scientists are unraveling the link between pollution and psoriasis

Researchers are uncovering how air pollution can trigger and worsen psoriasis, a chronic skin disease affecting millions ...

I was allergic to living in the UK, my skin would crack open and I’d bleed everywhere, everything changed when I left

SEEING the raincloud icon on your weather app is enough to dampen any Brit’s mood but for Rosie Daniels it meant agonising ...

Protagonist Announces Presentations of Clinical Data with Icotrokinra in Plaque Psoriasis and Preclinical Data with PN-881 at the EADV 2025 Congress

Icotrokinra demonstrated superior skin clearance at Weeks 16 and 24 compared to deucravacitinib and similar adverse event ...